Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
CeraVe taps Carmelo Anthony as ‘head coach’ of its new dandruff campaign
CeraVe found that the NBA and Carmelo Anthony could give it access to a very diverse, engaged and Gen Z fandom.
Digiday Programmatic Marketing Summit May Recap: How marketers are navigating agentic ad buying
Execs are already using AI agents to buy ads. At DPMS, they shared what’s worked (and what hasn’t) and the guardrails that the industry needs to put in place to future proof.
Future of Marketing Briefing: The brands winning at AI started with process not tech
The AI agent conversation is a distraction. Here’s what matters more.